Key result
Troponin I assessment at 24 hours strongly correlated with new myocyte necrosis and predicted type V MI with 88% sensitivity and 97% specificity, outperforming CK-MB.
Why the study?
Do cardiac biomarkers (Troponin I and CK-MB) accurately diagnose type V myocardial infarction after CABG compared to cardiac MRI?
RCT (n=40)
No
Do cardiac biomarkers (Troponin I and CK-MB) accurately diagnose type V myocardial infarction after CABG compared to cardiac MRI?
Troponin I alone at 24 hours is highly accurate for detecting type V myocardial infarction after CABG, potentially challenging the need for supplementary evidence required by current guidelines.
Answers are grounded in this paper and cite their sources.
TnI at 24 hours may aid type V MI diagnosis after CABG; leaves open whether it replaces CMR or guideline thresholds.
OBJECTIVES: To examine, using cardiac magnetic resonance (CMR), the utility of cardiac biomarkers for the determination of myocyte necrosis and function after coronary artery bypass grafting (CABG), and to test the recently updated guidelines for the diagnosis of postoperative myocardial infarction (type V MI). METHODS AND RESULTS: Forty patients included in a single-centre randomised trial of two surgical techniques for performing CABG underwent serial assessment with CMR biochemical markers. Cine and delayed enhancement CMR (DE-CMR) for assessment of left ventricular (LV) function and irreversible myocyte necrosis was performed and levels of troponin I (TnI) and creatine kinase-MB isoform (CK-MB) were determined. The area under the curve for TnI strongly correlated with the mass of new myocyte necrosis as assessed by DE-CMR (r = 0.83, p<0.001), compared with CK-MB (r=0.39, p=0.06). Furthermore, routine assessment of TnI alone at 24 h (> 6.6 μg/l) predicted type V MI on DE-CMR with a sensitivity of 88% and specificity of 97%, whereas CK-MB predicted type V MI with a sensitivity of 75% and specificity of 87%. CONCLUSIONS: Biomarkers alone (TnI), at an appropriate threshold appear robust for the detection of type V MI, independently of supplementary evidence, as suggested by the ESC/ACCF/AHA/WHF criteria. Clinical trial registration information The study is listed on the Current Controlled Trials Registry: ISRCTN41388968. URL: http://www.controlled-trials.com.
No takes yet. Share an insight, caveat, or question.
Pegg et al. (2011) conducted an RCT in Type V myocardial infarction after CABG (n=40). Troponin I (TnI) vs. Creatine kinase-MB (CK-MB) was evaluated on Mass of new myocyte necrosis as assessed by DE-CMR (r = 0.83, p=<0.001). Troponin I assessment at 24 hours strongly correlated with new myocyte necrosis and predicted type V MI with 88% sensitivity and 97% specificity, outperforming CK-MB.
Synapse has enriched 10 related papers. Consider them for comparative context: